Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Niannian Ji
Percutaneous BCG Enhances Innate Effector Antitumor Cytotoxicity During Treatment of Bladder Cancer: A Translational Clinical Trial
OncoImmunology
Oncology
Allergy
Immunology
Related publications
A Possible Mechanism of Intravesical BCG Therapy for Human Bladder Carcinoma: Involvement of Innate Effector Cells for the Inhibition of Tumor Growth
Cancer Immunology, Immunotherapy
Cancer Research
Medicine
Oncology
Allergy
Immunology
1,25D3 Enhances Antitumor Activity of Gemcitabine and Cisplatin in Human Bladder Cancer Models
Cancer
Cancer Research
Oncology
Who Should Be Included in a Clinical Trial of Screening for Bladder Cancer?
Cancer
Cancer Research
Oncology
Effect of Anticoagulants and Antiplatelet Agents on the Efficacy of Intravesical BCG Treatment of Bladder Cancer: A Systematic Review
Canadian Urological Association Journal
Urology
Granulomatous Prostatitis Diagnosed During Intravesical BCG Treatment
Turk Uroloji Dergisi
Urology
Study Protocol of a Phase II Clinical Trial of Oral Metformin for the Intravesical Treatment of Non-Muscle Invasive Bladder Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
A Phase I Study of an Intravesically Administered Immunotoxin Targeting EpCAM for the Treatment of Nonmuscle-Invasive Bladder Cancer in BCG-refractory and BCG-intolerant Patients
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Legal Basic of BCG-Therapy for Bladder Cancer in Municipal Polyclinics
Tuberkulëz i bolezni lëgkikh
Pulmonary
Infectious Diseases
Respiratory Medicine
Mp65-17 Intravesical Thalidomide Boosts Bacillus Calmete-Guérin (Bcg) in Non-Muscle Invasive Bladder Cancer Treatment
Journal of Urology
Urology
